Post on 23-Feb-2016
description
Gout: It didn't need to come to this!
Presenter:
Speaker Disclosure Statement
Name of presenter/speaker
Gout: It didn't need to come to this!
Financial Disclosure: – Grants/Research Support – Speaker Bureau/Honoraria – Consulting Fees – Other
• 86% (71/81) of patients who had serum urate <360 µmol/L did not experience an acute flare during the study period
%
Mean Serum Urate, µmol/L
Per
cent
age
of P
atie
nts
With
G
out F
lare
Rec
urre
nce
300 480 5100
20
40
60
80
100
Reduction in Acute Flaresin Years 2 and 3 of Treatment1
N = 267
.
.
0
10
20
30
40
50
0-4 4-8 8-12 12-16 16-20 20-24 24-28
Subj
ects
, %
Febuxostat 40 mg
Febuxostat 80 mg Allopurinol 300/200 mg